Tereza Smejkalova

7PUBLICATIONS
33CO-AUTHORS
Genetically modified animalsEpigenetics (incl. genome methylation and epigenomics)Neurology and neuromuscular diseasesCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 30, 2026
Mice carrying a GluN2B protein-truncating variant have altered NMDA receptor subunit composition and their behavior recapitulates patient phenotypes.

Klevinda Fili, Viktor Kuchtiak, Eni Tomovic

|Jun 26, 2024
Characterization of Mice Carrying a Neurodevelopmental Disease-Associated GluN2B(L825V) Variant.

Miriam Candelas Serra, Viktor Kuchtiak, Agnieszka Kubik-Zahorodna

|Jan 12, 2024
Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.

Bohdan Kysilov, Viktor Kuchtiak, Barbora Hrcka Krausova

|Mar 23, 2022
Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.

Bohdan Kysilov, Barbora Hrcka Krausova, Vojtech Vyklicky

|Sep 14, 2021
Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats.

Kristýna Štefková-Mazochová, Hynek Danda, Wim Dehaen

|May 14, 2021
Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms.

Tereza Smejkalova, Miloslav Korinek, Jan Krusek

Pageof 2

Frequent Collaborators

5 joint publications

Jiri Cerny

5 joint publications

Ladislav Vyklicky

3 joint publications

Ales Balik

3 joint publications

Miloslav Korinek